Latest Insider Transactions at Heart Beam, Inc. (BEAT)
This section provides a real-time view of insider transactions for Heart Beam, Inc. (BEAT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HeartBeam, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HeartBeam, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 06
2024
|
George De Urioste Director |
SELL
Open market or private sale
|
Direct |
1,674
-2.85%
|
$3,348
$2.34 P/Share
|
Aug 30
2024
|
George De Urioste Director |
SELL
Open market or private sale
|
Direct |
5,500
-8.55%
|
$11,000
$2.31 P/Share
|
Aug 27
2024
|
George De Urioste Director |
SELL
Open market or private sale
|
Direct |
2,194
-3.3%
|
$4,388
$2.26 P/Share
|
Aug 26
2024
|
George De Urioste Director |
SELL
Open market or private sale
|
Direct |
300
-0.45%
|
$600
$2.38 P/Share
|
Aug 23
2024
|
George De Urioste Director |
SELL
Open market or private sale
|
Direct |
2,500
-3.61%
|
$5,000
$2.3 P/Share
|
Jun 12
2024
|
Kenneth Warwick Nelson Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,185
+20.7%
|
-
|
Jun 12
2024
|
Michael R Jaff Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,185
+30.64%
|
-
|
Jun 12
2024
|
Willem Elfrink Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,185
+9.45%
|
-
|
Jun 12
2024
|
Mark E Strome > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
33,185
+36.74%
|
-
|
Jun 12
2024
|
George De Urioste Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,185
+32.38%
|
-
|
Jun 12
2024
|
Marga Ortigas Wedekind Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,185
+22.81%
|
-
|
Jun 12
2024
|
Richard Ferrari Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,247
+22.81%
|
-
|
Sep 29
2023
|
George De Urioste Director |
SELL
Open market or private sale
|
Direct |
5,500
-13.21%
|
$11,000
$2.06 P/Share
|
Sep 28
2023
|
George De Urioste Director |
SELL
Open market or private sale
|
Direct |
8,000
-16.12%
|
$16,000
$2.04 P/Share
|
Sep 27
2023
|
George De Urioste Director |
SELL
Open market or private sale
|
Direct |
1,834
-3.56%
|
$3,668
$2.11 P/Share
|
Sep 26
2023
|
George De Urioste Director |
SELL
Open market or private sale
|
Direct |
5,000
-8.86%
|
$10,000
$2.09 P/Share
|
Sep 22
2023
|
George De Urioste Director |
SELL
Open market or private sale
|
Direct |
2,393
-4.07%
|
$4,786
$2.21 P/Share
|
Sep 21
2023
|
George De Urioste Director |
SELL
Open market or private sale
|
Direct |
100
-0.17%
|
$200
$2.41 P/Share
|
Sep 20
2023
|
George De Urioste Director |
SELL
Open market or private sale
|
Direct |
883
-1.48%
|
$1,766
$2.46 P/Share
|
Sep 18
2023
|
George De Urioste Director |
SELL
Open market or private sale
|
Direct |
5,000
-7.71%
|
$10,000
$2.46 P/Share
|
Sep 15
2023
|
George De Urioste Director |
SELL
Open market or private sale
|
Direct |
4,269
-6.18%
|
$8,538
$2.43 P/Share
|
Sep 14
2023
|
George De Urioste Director |
SELL
Open market or private sale
|
Direct |
5,000
-6.75%
|
$10,000
$2.17 P/Share
|
Sep 13
2023
|
George De Urioste Director |
SELL
Open market or private sale
|
Direct |
5,000
-3.21%
|
$5,000
$1.93 P/Share
|
Jul 13
2023
|
Willem Elfrink Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,961
+7.76%
|
-
|
Jul 13
2023
|
Richard Ferrari Director |
BUY
Grant, award, or other acquisition
|
Direct |
31,948
+23.25%
|
-
|
Jul 13
2023
|
Mark E Strome > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
23,961
+50.0%
|
-
|
Jul 13
2023
|
Kenneth Warwick Nelson Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,961
+20.32%
|
-
|
Jul 13
2023
|
George De Urioste Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,961
+23.25%
|
-
|
Jul 13
2023
|
Marga Ortigas Wedekind Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,961
+23.25%
|
-
|
Feb 10
2023
|
Richard Brounstein Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
184
+0.16%
|
-
|
Feb 10
2023
|
Branislav Vajdic CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,287
+0.14%
|
-
|
Feb 09
2023
|
Willem Elfrink Director |
BUY
Conversion of derivative security
|
Direct |
3,640
+1.14%
|
$7,280
$2.75 P/Share
|
Feb 09
2023
|
Willem Elfrink Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
125,351
-28.63%
|
-
|
Dec 02
2022
|
Richard Brounstein Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
760
+0.67%
|
-
|
Nov 02
2022
|
Richard Brounstein Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
759
+0.68%
|
-
|
Oct 02
2022
|
Richard Brounstein Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
760
+0.68%
|
-
|
Sep 02
2022
|
Richard Brounstein Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
757
+0.69%
|
-
|
Aug 01
2022
|
Richard Brounstein Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
757
+0.69%
|
-
|
Jul 15
2022
|
George De Urioste Director |
BUY
Grant, award, or other acquisition
|
Direct |
55,147
+50.0%
|
-
|
Jul 15
2022
|
Marga Ortigas Wedekind Director |
BUY
Grant, award, or other acquisition
|
Direct |
55,147
+50.0%
|
-
|
Jul 15
2022
|
Richard Ferrari Director |
BUY
Grant, award, or other acquisition
|
Direct |
73,529
+50.0%
|
-
|
Jul 15
2022
|
Willem Elfrink Director |
BUY
Grant, award, or other acquisition
|
Direct |
55,147
+19.93%
|
-
|
Jul 05
2022
|
Richard Brounstein Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
757
+0.7%
|
$757
$1.3 P/Share
|
Jun 02
2022
|
Richard Brounstein Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
757
+0.7%
|
-
|
May 02
2022
|
Richard Brounstein Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
757
+0.71%
|
-
|
Apr 04
2022
|
Richard Brounstein Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
757
+0.71%
|
-
|
Mar 02
2022
|
Richard Brounstein Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
757
+0.72%
|
-
|
Feb 02
2022
|
Richard Brounstein Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
757
+0.72%
|
-
|
Jan 02
2022
|
Richard Brounstein Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,514
+1.44%
|
-
|
Dec 21
2021
|
Richard Brounstein Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+4.67%
|
$15,000
$3.37 P/Share
|